MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth

Cancer Letters

Volumn 333, Issue 2, 2013, Pages 159-169

  Zhou, Bisheng ^a   Ma, Ruihua ^b   Si, Wenxia ^a   Li, Sisi ^a   Xu, Yan ^a   Tu, Xin ^a   Wang, Qing ^a,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; FGF2; Methylation; MiR 503; VEGFA

Indexed keywords

AGO MICRORNA 503; ANTINEOPLASTIC AGENT; FIBROBLAST GROWTH FACTOR 2; GENOMIC DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MICRORNA 503; UNCLASSIFIED DRUG; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER INHIBITION; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE FUNCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; RNA METHYLATION; TREATMENT RESPONSE; TUMOR VOLUME; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; DOWN-REGULATION; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84876737342     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.028     Document Type: Article

References (45)

1. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003, 9:653-660.
2. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
3. Cross M.J., Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 2001, 22:201-207.
4. Przybylski M. A review of the current research on the role of bFGF and VEGF in angiogenesis. J. Wound Care 2009, 18:516-519.
5. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002, 2:38-47.
6. Ryan H.E., Lo J., Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998, 17:3005-3015.
7. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362:841-844.
8. Ruan K., Fang X., Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 2009, 285:116-126.
9. Wang S., Olson E.N. AngiomiRs-key regulators of angiogenesis. Curr. Opin. Genet. Dev. 2009, 19:205-211.
10. Suarez Y., Sessa W.C. MicroRNAs as novel regulators of angiogenesis. Circ. Res. 2009, 104:442-454.
11. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 2005, 37:766-770.
12. Sewer A., Paul N., Landgraf P., Aravin A., Pfeffer S., Brownstein M.J., Tuschl T., van Nimwegen E., Zavolan M. Identification of clustered microRNAs using an ab initio prediction method. BMC Bioinformatics 2005, 6:267.
13. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foa R., Schliwka J., Fuchs U., Novosel A., Muller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
14. Caporali A., Meloni M., Vollenkle C., Bonci D., Sala-Newby G.B., Addis R., Spinetti G., Losa S., Masson R., Baker A.H., Agami R., le Sage C., Condorelli G., Madeddu P., Martelli F., Emanueli C. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis After Limb Ischemia. Circulation 2011, 123:282-291.
15. Tian X.L., Kadaba R., You S.A., Liu M., Timur A.A., Yang L., Chen Q., Szafranski P., Rao S., Wu L., Housman D.E., DiCorleto P.E., Driscoll D.J., Borrow J., Wang Q. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 2004, 427:640-645.
16. Fan C., Ouyang P., Timur A.A., He P., You S.A., Hu Y., Ke T., Driscoll D.J., Chen Q., Wang Q.K. Novel roles of GATA1 in regulation of angiogenic factor AGGF1 and endothelial cell function. J. Biol. Chem. 2009, 284:23331-23343.
17. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., Barbisin M., Xu N.L., Mahuvakar V.R., Andersen M.R., Lao K.Q., Livak K.J., Guegler K.J. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33:e179.
18. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
19. Shih T.C., Tien Y.J., Wen C.J., Yeh T.S., Yu M.C., Huang C.H., Lee Y.S., Yen T.C., Hsieh S.Y. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J. Hepatol. 2012, 57:584-591.
20. Fang J.H., Zhou H.C., Zeng C., Yang J., Liu Y., Huang X., Zhang J.P., Guan X.Y., Zhuang S.M. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 2011, 54:1729-1740.
21. Kim K.W., Bae S.K., Lee O.H., Bae M.H., Lee M.J., Park B.C. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res. 1998, 58:348-351.
22. Yoshikawa T., Tsuburaya A., Kobayashi O., Sairenji M., Motohashi H., Yanoma S., Noguchi Y. Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma. Cancer Lett. 2000, 153:7-12.
23. Ardi V.C., Van den Steen P.E., Opdenakker G., Schweighofer B., Deryugina E.I., Quigley J.P. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J. Biol. Chem. 2009, 284:25854-25866.
24. Zhang B.L., Feng S.P., Cong S.J., Zhang X., Bao X.C., Wang W., Li H.P., Wang Z., Wang G.X., Xu J.Z., Du B.W., Qu D.Z., Xiong W., Yin M.H., Ren X.S., Wang F.F., He J.X. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res. 2011, 39:6669-6678.
25. Wang J., Ma Y., Jiang H., Zhu H., Liu L., Sun B., Pan S., Krissansen G.W., Sun X. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice. J. Hepatol. 2011, 55:359-368.
26. Huang B., Lei Z., Zhang G.M., Li D., Song C., Li B., Liu Y., Yuan Y., Unkeless J., Xiong H., Feng Z.H. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008, 112:1269-1279.
27. Kyzas P.A., Stefanou D., Batistatou A., Agnantis N.J. Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study. Cancer Lett. 2005, 225:297-304.
28. Alpini G., Glaser S.S., Zhang J.P., Francis H., Han Y., Gong J., Stokes A., Francis T., Hughart N., Hubble L., Zhuang S.M., Meng F. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J. Hepatol. 2011, 55:1339-1345.
29. Ku J.L., Kang S.B., Shin Y.K., Kang H.C., Hong S.H., Kim I.J., Shin J.H., Han I.O., Park J.G. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 2004, 23:6736-6742.
30. Zhou J., Wang W. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell. J. Surg. Oncol. 2011, 104:278-283.
31. Calvani M., Rapisarda A., Uranchimeg B., Shoemaker R.H., Melillo G. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 2006, 107:2705-2712.
32. Kim K.R., Moon H.E., Kim K.W. Hypoxia-induced angiogenesis in human hepatocellular carcinoma. J. Mol. Med. (Berl.) 2002, 80:703-714.
33. Z.Z. Dong, M. Yao, L. Wang, W. Wu, D.F. Yao, Hypoxia-inducible Factor-1alpha: Molecular-targeted Therapy for Hepatocellular Carcinoma, Mini Reviews in Medicinal Chemistry, 2012.
34. Kulshreshtha R., Ferracin M., Wojcik S.E., Garzon R., Alder H., Agosto-Perez F.J., Davuluri R., Liu C.G., Croce C.M., Negrini M., Calin G.A., Ivan M. A microRNA signature of hypoxia. Mol. Cell Biol. 2007, 27:1859-1867.
35. Dejean E., Renalier M.H., Foisseau M., Agirre X., Joseph N., de Paiva G.R., Al Saati T., Soulier J., Desjobert C., Lamant L., Prosper F., Felsher D.W., Cavaille J., Prats H., Delsol G., Giuriato S., Meggetto F. Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia 2011, 25:1882-1890.
36. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
37. Kim J., Kang Y., Kojima Y., Lighthouse J.K., Hu X., Aldred M.A., McLean D.L., Park H., Comhair S.A., Greif D.M., Erzurum S.C., Chun H.J. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat. Med. 2012.
38. Yin K.J., Olsen K., Hamblin M., Zhang J., Schwendeman S.P., Chen Y.E. Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia. J. Biol. Chem. 2012, 287:27055-27064.
39. Liu B., Peng X.C., Zheng X.L., Wang J., Qin Y.W. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009, 66:169-175.
40. Long J., Wang Y., Wang W., Chang B.H., Danesh F.R. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J. Biol. Chem. 2010, 285:23457-23465.
41. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
42. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
43. Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett. 2012, 320:130-137.
44. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
45. Kuwabara K., Ogawa S., Matsumoto M., Koga S., Clauss M., Pinsky D.J., Lyn P., Leavy J., Witte L., Joseph-Silverstein J., et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl. Acad. Sci. USA 1995, 92:4606-4610.